abobotulinumtoxinA
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Rapacuronium.
Acetyldigitoxin
Rapacuronium may increase the arrhythmogenic activities of Acetyldigitoxin.
Aclarubicin
Aclarubicin may increase the respiratory depressant activities of Rapacuronium.
Advertisement
Alclometasone
Rapacuronium may increase the adverse neuromuscular activities of Alclometasone.
Aldosterone
Rapacuronium may increase the adverse neuromuscular activities of Aldosterone.
Ambenonium
Ambenonium may decrease the neuromuscular blocking activities of Rapacuronium.
Advertisement
Amcinonide
Rapacuronium may increase the adverse neuromuscular activities of Amcinonide.
Amikacin
Amikacin may increase the respiratory depressant activities of Rapacuronium.
Androstenedione
Rapacuronium may increase the adverse neuromuscular activities of Androstenedione.
Advertisement
Arbekacin
Arbekacin may increase the respiratory depressant activities of Rapacuronium.
Azosemide
Azosemide may decrease the neuromuscular blocking activities of Rapacuronium.
Beclomethasone Dipropionate
Rapacuronium may increase the adverse neuromuscular activities of Beclomethasone dipropionate.
Betamethasone
Rapacuronium may increase the adverse neuromuscular activities of Betamethasone.
Botulinum Toxin Type A
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Rapacuronium.
Budesonide
Rapacuronium may increase the adverse neuromuscular activities of Budesonide.
Bumetanide
Bumetanide may decrease the neuromuscular blocking activities of Rapacuronium.
Capreomycin
Capreomycin may increase the neuromuscular blocking activities of Rapacuronium.
Chlortetracycline
Chlortetracycline may increase the neuromuscular blocking activities of Rapacuronium.
Ciclesonide
Rapacuronium may increase the adverse neuromuscular activities of Ciclesonide.
Clindamycin
Clindamycin may increase the neuromuscular blocking activities of Rapacuronium.
Clobetasol
Rapacuronium may increase the adverse neuromuscular activities of Clobetasol.
Clobetasol Propionate
Rapacuronium may increase the adverse neuromuscular activities of Clobetasol propionate.
Clobetasone
Rapacuronium may increase the adverse neuromuscular activities of Clobetasone.
Clocortolone
Rapacuronium may increase the adverse neuromuscular activities of Clocortolone.
Colistimethate
Colistimethate may increase the neuromuscular blocking activities of Rapacuronium.
Cortisone Acetate
Rapacuronium may increase the adverse neuromuscular activities of Cortisone acetate.
Cyclosporine
Cyclosporine may increase the neuromuscular blocking activities of Rapacuronium.
Daunorubicin
Daunorubicin may increase the respiratory depressant activities of Rapacuronium.
Deflazacort
Rapacuronium may increase the adverse neuromuscular activities of Deflazacort.
Demecarium
Demecarium may decrease the neuromuscular blocking activities of Rapacuronium.
Demeclocycline
Demeclocycline may increase the neuromuscular blocking activities of Rapacuronium.
Desflurane
Desflurane may increase the neuromuscular blocking activities of Rapacuronium.
Deslanoside
Rapacuronium may increase the arrhythmogenic activities of Deslanoside.
Desonide
Rapacuronium may increase the adverse neuromuscular activities of Desonide.
Desoximetasone
Rapacuronium may increase the adverse neuromuscular activities of Desoximetasone.
Desoxycorticosterone acetate
Rapacuronium may increase the adverse neuromuscular activities of Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
Rapacuronium may increase the adverse neuromuscular activities of Desoxycorticosterone Pivalate.
Dexamethasone
Rapacuronium may increase the adverse neuromuscular activities of Dexamethasone.
Diflorasone
Rapacuronium may increase the adverse neuromuscular activities of Diflorasone.
Diflucortolone
Rapacuronium may increase the adverse neuromuscular activities of Difluocortolone.
Difluprednate
Rapacuronium may increase the adverse neuromuscular activities of Difluprednate.
Digitoxin
Rapacuronium may increase the arrhythmogenic activities of Digitoxin.
Digoxin
Rapacuronium may increase the arrhythmogenic activities of Digoxin.
Dihydrostreptomycin
Dihydrostreptomycin may increase the respiratory depressant activities of Rapacuronium.
Distigmine
Distigmine may decrease the neuromuscular blocking activities of Rapacuronium.
Donepezil
Donepezil may decrease the neuromuscular blocking activities of Rapacuronium.
Doxorubicin
Doxorubicin may increase the respiratory depressant activities of Rapacuronium.
Doxorubicin Hydrochloride
Doxorubicin may increase the respiratory depressant activities of Rapacuronium.
Doxycycline
Doxycycline may increase the neuromuscular blocking activities of Rapacuronium.
Doxycycline Anhydrous
Doxycycline may increase the neuromuscular blocking activities of Rapacuronium.
Echothiophate
Echothiophate may decrease the neuromuscular blocking activities of Rapacuronium.
Edrophonium
Edrophonium may decrease the neuromuscular blocking activities of Rapacuronium.
Enflurane
Enflurane may increase the neuromuscular blocking activities of Rapacuronium.
Epirubicin
Epirubicin may increase the respiratory depressant activities of Rapacuronium.
Estrone
Rapacuronium may increase the adverse neuromuscular activities of Estrone.
Ethacrynate
Etacrynic acid may decrease the neuromuscular blocking activities of Rapacuronium.
Ethacrynic Acid
Etacrynic acid may decrease the neuromuscular blocking activities of Rapacuronium.
Fludrocortisone
Rapacuronium may increase the adverse neuromuscular activities of Fludrocortisone.
Flumethasone
Rapacuronium may increase the adverse neuromuscular activities of Flumethasone.
Flunisolide
Rapacuronium may increase the adverse neuromuscular activities of Flunisolide.
Flunisolide Anhydrous (obsolete)
Rapacuronium may increase the adverse neuromuscular activities of Flunisolide.
Fluocinolone Acetonide
Rapacuronium may increase the adverse neuromuscular activities of Fluocinolone Acetonide.
Fluocinonide
Rapacuronium may increase the adverse neuromuscular activities of Fluocinonide.
Fluocortolone
Rapacuronium may increase the adverse neuromuscular activities of Fluocortolone.
Fluorometholone
Rapacuronium may increase the adverse neuromuscular activities of Fluorometholone.
FLUPREDNIDENE
Rapacuronium may increase the adverse neuromuscular activities of Fluprednidene.
Fluprednisolone
Rapacuronium may increase the adverse neuromuscular activities of Fluprednisolone.
Flurandrenolide
Rapacuronium may increase the adverse neuromuscular activities of Flurandrenolide.
Fluticasone Furoate
Rapacuronium may increase the adverse neuromuscular activities of Fluticasone furoate.
Fluticasone propionate
Rapacuronium may increase the adverse neuromuscular activities of Fluticasone propionate.
Formestane
Rapacuronium may increase the adverse neuromuscular activities of Formestane.
Fosphenytoin
Fosphenytoin may decrease the neuromuscular blocking activities of Rapacuronium.
Framycetin
Framycetin may increase the respiratory depressant activities of Rapacuronium.
Furosemide
Furosemide may decrease the neuromuscular blocking activities of Rapacuronium.
Galantamine
Galantamine may decrease the neuromuscular blocking activities of Rapacuronium.
Gallamine Triethiodide
Gallamine Triethiodide may decrease the neuromuscular blocking activities of Rapacuronium.
Gentamicin
Gentamicin may increase the respiratory depressant activities of Rapacuronium.
Ginkgo biloba extract
Ginkgo biloba may decrease the neuromuscular blocking activities of Rapacuronium.
Halcinonide
Rapacuronium may increase the adverse neuromuscular activities of Halcinonide.
Halobetasol
Rapacuronium may increase the adverse neuromuscular activities of Ulobetasol.
Halothane
Halothane may increase the neuromuscular blocking activities of Rapacuronium.
Hydrocortisone
Rapacuronium may increase the adverse neuromuscular activities of Hydrocortisone.
Idarubicin
Idarubicin may increase the respiratory depressant activities of Rapacuronium.
incobotulinumtoxinA
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Rapacuronium.
Isoflurane
Isoflurane may increase the neuromuscular blocking activities of Rapacuronium.
Isoflurophate
Isoflurophate may decrease the neuromuscular blocking activities of Rapacuronium.
Kanamycin
Kanamycin may increase the respiratory depressant activities of Rapacuronium.
kanamycin A
Kanamycin may increase the respiratory depressant activities of Rapacuronium.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Rapacuronium.
Lincomycin
Lincomycin may increase the neuromuscular blocking activities of Rapacuronium.
Lithium
Lithium may increase the neuromuscular blocking activities of Rapacuronium.
Lithium Cation
Lithium may increase the neuromuscular blocking activities of Rapacuronium.
Loteprednol
Rapacuronium may increase the adverse neuromuscular activities of Loteprednol.
Magnesium Hydroxide
Magnesium hydroxide may increase the neuromuscular blocking activities of Rapacuronium.
Magnesium Oxide
Magnesium oxide may increase the neuromuscular blocking activities of Rapacuronium.
Magnesium Salicylate
Magnesium salicylate may increase the neuromuscular blocking activities of Rapacuronium.
Magnesium Sulfate
Magnesium sulfate may increase the neuromuscular blocking activities of Rapacuronium.
MAGNESIUM SULFATE ANHYDROUS
Magnesium sulfate may increase the neuromuscular blocking activities of Rapacuronium.
Malathion
Malathion may decrease the neuromuscular blocking activities of Rapacuronium.
Medrysone
Rapacuronium may increase the adverse neuromuscular activities of Medrysone.
Mefloquine
Mefloquine may decrease the neuromuscular blocking activities of Rapacuronium.
Memantine
Memantine may decrease the neuromuscular blocking activities of Rapacuronium.
Methoxyflurane
Methoxyflurane may increase the neuromuscular blocking activities of Rapacuronium.
Methylprednisolone
Rapacuronium may increase the adverse neuromuscular activities of Methylprednisolone.
Metoclopramide
Metoclopramide may decrease the neuromuscular blocking activities of Rapacuronium.
Metrizamide
Metrizamide may increase the respiratory depressant activities of Rapacuronium.
Minaprine
Minaprine may decrease the neuromuscular blocking activities of Rapacuronium.
Minocycline
Minocycline may increase the neuromuscular blocking activities of Rapacuronium.
Mometasone
Rapacuronium may increase the adverse neuromuscular activities of Mometasone.
Neomycin
Neomycin may increase the respiratory depressant activities of Rapacuronium.
Neostigmine
Neostigmine may decrease the neuromuscular blocking activities of Rapacuronium.
Netilmicin
Netilmicin may increase the respiratory depressant activities of Rapacuronium.
Nitrous Oxide
Nitrous oxide may increase the neuromuscular blocking activities of Rapacuronium.
O-PHENANTHROLINE
1,10-Phenanthroline may decrease the neuromuscular blocking activities of Rapacuronium.
onabotulinumtoxinA
Botulinum Toxin Type A may increase the neuromuscular blocking activities of Rapacuronium.
Ouabain
Rapacuronium may increase the arrhythmogenic activities of Ouabain.
Ovine Digoxin Immune Fab
Rapacuronium may increase the arrhythmogenic activities of Digoxin Immune Fab (Ovine).
Paramethasone
Rapacuronium may increase the adverse neuromuscular activities of Paramethasone.
Paromomycin
Paromomycin may increase the respiratory depressant activities of Rapacuronium.
Phenytoin
Phenytoin may decrease the neuromuscular blocking activities of Rapacuronium.
Physostigmine
Physostigmine may decrease the neuromuscular blocking activities of Rapacuronium.
Pirarubicin
Pirarubicin may increase the respiratory depressant activities of Rapacuronium.
Piretanide
Piretanide may decrease the neuromuscular blocking activities of Rapacuronium.
Plicamycin
Plicamycin may increase the respiratory depressant activities of Rapacuronium.
Polymyxin B
Polymyxin B Sulfate may increase the neuromuscular blocking activities of Rapacuronium.
Polymyxin B Sulfate
Polymyxin B Sulfate may increase the neuromuscular blocking activities of Rapacuronium.
Prasterone
Rapacuronium may increase the adverse neuromuscular activities of Prasterone.
Prednicarbate
Rapacuronium may increase the adverse neuromuscular activities of Prednicarbate.
Prednisolone
Rapacuronium may increase the adverse neuromuscular activities of Prednisolone.
Prednisone
Rapacuronium may increase the adverse neuromuscular activities of Prednisone.
Pregnenolone
Rapacuronium may increase the adverse neuromuscular activities of Pregnenolone.
Procainamide
Procainamide may increase the neuromuscular blocking activities of Rapacuronium.
Proscillaridin
Rapacuronium may increase the arrhythmogenic activities of Proscillaridin.
Pyridostigmine
Pyridostigmine may decrease the neuromuscular blocking activities of Rapacuronium.
Pyridostigmine Bromide
Pyridostigmine may decrease the neuromuscular blocking activities of Rapacuronium.
Quinidine
Quinidine may increase the neuromuscular blocking activities of Rapacuronium.
Quinine
Quinine may increase the neuromuscular blocking activities of Rapacuronium.
rimabotulinumtoxinB
Rapacuronium may increase the neuromuscular blocking activities of Botulinum Toxin Type B.
Rimexolone
Rapacuronium may increase the adverse neuromuscular activities of Rimexolone.
Rivastigmine
Rivastigmine may decrease the neuromuscular blocking activities of Rapacuronium.
Sevoflurane
Sevoflurane may increase the neuromuscular blocking activities of Rapacuronium.
Sisomicin
Sisomicin may increase the respiratory depressant activities of Rapacuronium.
Spectinomycin
Spectinomycin may increase the respiratory depressant activities of Rapacuronium.
Spironolactone
Spironolactone may increase the neuromuscular blocking activities of Rapacuronium.
Streptomycin
Streptomycin may increase the respiratory depressant activities of Rapacuronium.
Streptozocin
Streptozocin may increase the respiratory depressant activities of Rapacuronium.
Tacrine
Tacrine may decrease the neuromuscular blocking activities of Rapacuronium.
Tixocortol
Rapacuronium may increase the adverse neuromuscular activities of Tixocortol.
Tobramycin
Tobramycin may increase the respiratory depressant activities of Rapacuronium.
Torsemide
Torasemide may decrease the neuromuscular blocking activities of Rapacuronium.
Triamcinolone
Rapacuronium may increase the adverse neuromuscular activities of Triamcinolone.
Tubocurarine
Tubocurarine may decrease the neuromuscular blocking activities of Rapacuronium.
Valrubicin
Valrubicin may increase the respiratory depressant activities of Rapacuronium.
Vancomycin
Vancomycin may increase the neuromuscular blocking activities of Rapacuronium.
